Interim Statement on the First Three Months of Financial Year 2025Cohort 7 of the clinical trial of HDP-101 in multiple myeloma safe and well toleratedCohort 8 expected to start soonClinical ...

The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.

Cancer ranks as one of the top causes of death worldwide. The National Cancer Institute reported nearly 20 million new cancer ...

Galleri blood test detects fifty cancers early via cfDNA analysis for adults 50+ with no symptoms, though not a standard ...

Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...

Artificial intelligence models, pretrained on vast datasets, significantly outperformed a standard baseline model in ...

A study uncovers intricate details about protein function at the molecular level. The discovery could transform disease diagnostics and treatment.

According to the results of the early study, published simultaneously in the New England Journal of Medicine, 92% of patients ...

In 2021, research led by Ryan Flynn, MD, Ph.D., and his mentor, Nobel laureate Carolyn Bertozzi, Ph.D., opened a new chapter ...

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

For those with surface skin cancer, new technology offers a non-surgical treatment option. Dr. Muennich is among the few in the country using image-guided superficial radiation therapy.